Comparison

Anti-Androgen Receptor (Ser94) Antibody

Item no. ABC-AN1311
Manufacturer Abcepta
Amount 100 ul
Category
Specific against other
Host Rabbit
Isotype IgG
Alias AIS antibody,ANDR_HUMAN antibody,Androgen nuclear receptor variant 2 antibody,Androgen receptor (dihydrotestosterone receptor,testicular feminization,spinal and bulbar muscular atrophy,Kennedy disease) antibody,Androgen receptor antibody,androgen receptor splice variant 4b antibody,AR antibody,AR8 antibody,DHTR antibody,Dihydro testosterone receptor antibody,Dihydrotestosterone receptor (DHTR) antibody,Dihydrotestosterone receptor antibody,HUMARA antibody,HYSP1 antibody,KD antibody,Kennedy disease (KD) antibody,NR3C4 antibody,Nuclear receptor subfamily 3 group C member 4 (NR3C4) antibody,Nuclear receptor subfamily 3 group C member 4 antibody,SBMA antibody,SMAX1 antibody,Spinal and bulbar muscular atrophy (SBMA) antibody,Spinal and bulbar muscular atrophy antibody,Testicular Feminization (TFM) antibody,TFM antibody
Available
Manufacturer - Category
Primary Antibodies; Cancer; Developmental Biology; Signal Transduction
Manufacturer - Targets
The androgen receptor (AR) is a DNA-binding transcription factor that regulates genes critical for the development and maintenance of the male sexual phenotype. Defects in androgen receptor have been shown to play a role in prostate cancer, and inhibition of AR activity through modulation of signal transduction pathways may delay prostate cancer progression (Heinlein and Chang 2004). Multiple phosphorylation sites have been identified on the androgen receptor that affect cross-talk between growth factor signaling and androgen in prostate development and cancer (Gioeli et al., 2002). One of these sites, at Ser94, appears constitutively phosphorylated and exhibits no response to treatments with stimulating hormone (Gioeli et al., 2002). The site at Ser94 is unique among the AR phosphorylation sites in that it does not achieve a maximal level of phosphorylation between translation and the initial round of nuclear import, having a strong bias for androgen-independent phosphorylation in the cytoplasm (Kesler et al., 2007).
Bio Background
The androgen receptor (AR) is a DNA-binding transcription factor that regulates genes critical for the development and maintenance of the male sexual phenotype. Defects in androgen receptor have been shown to play a role in prostate cancer, and inhibition of AR activity through modulation of signal transduction pathways may delay prostate cancer progression (Heinlein and Chang 2004). Multiple phosphorylation sites have been identified on the androgen receptor that affect cross-talk between growth factor signaling and androgen in prostate development and cancer (Gioeli et al., 2002). One of these sites, at Ser94, appears constitutively phosphorylated and exhibits no response to treatments with stimulating hormone (Gioeli et al., 2002). The site at Ser94 is unique among the AR phosphorylation sites in that it does not achieve a maximal level of phosphorylation between translation and the initial round of nuclear import, having a strong bias for androgen-independent phosphorylation in the cytoplasm (Kesler et al., 2007).
Clonality
Polyclonal
Gene Name
AR
Subtitle
Our Anti-Androgen Receptor (Ser94) rabbit polyclonal phosphospecific primary antibody from PhosphoSo
Calculated Molecular Weight
99188
Formulation
Antigen Affinity Purified from Pooled Serum

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 ul
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close